Imbalanced cross-overs [Study Per­for­mance]

posted by khaoula – Algeria, 2014-06-06 18:03 (3977 d 23:52 ago) – Posting: # 13039
Views: 18,398

Hi Helmut,

❝ I don’t understand what you mean here. The limit for HVDs/HVDPs is 30% CV of the reference obtained in a replicate design. CVintra from a 2×2 serves only as a hint of a highly variable reference (since pooled from CVWR and CVWT).


this is a real study that was done in the institute were I do my post graduate disertation, and the drug is omeprazole, that is a HVDP (in bibliography I read a lot of bioequivalence stydy were CV > 30%) I know that the cross over isn't adapted for this, but CV C max of the study Was very low!!!!!!!!

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,667 registered users;
27 visitors (0 registered, 27 guests [including 9 identified bots]).
Forum time: 17:56 CEST (Europe/Vienna)

It is true that many scientists are not philosophically minded
and have hitherto shown much skill and ingenuity
but little wisdom.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5